Enping Xu

3.1k total citations
49 papers, 2.3k citations indexed

About

Enping Xu is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Enping Xu has authored 49 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Molecular Biology, 19 papers in Cancer Research and 14 papers in Oncology. Recurrent topics in Enping Xu's work include RNA modifications and cancer (12 papers), Cancer-related molecular mechanisms research (8 papers) and Genetic factors in colorectal cancer (8 papers). Enping Xu is often cited by papers focused on RNA modifications and cancer (12 papers), Cancer-related molecular mechanisms research (8 papers) and Genetic factors in colorectal cancer (8 papers). Enping Xu collaborates with scholars based in China, United States and Austria. Enping Xu's co-authors include Maode Lai, Honghe Zhang, Ledong Wan, Yihua Wu, Qiong Huang, Maode Lai, Jianlu Kong, Hui Cao, Wenjie Sun and Hong Liu and has published in prestigious journals such as Journal of Clinical Oncology, Analytical Chemistry and Cancer.

In The Last Decade

Enping Xu

48 papers receiving 2.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Enping Xu China 25 1.4k 1.0k 606 272 246 49 2.3k
Hua Ye China 27 1.7k 1.2× 1.2k 1.2× 481 0.8× 219 0.8× 452 1.8× 136 2.8k
Giacomo Manenti Italy 30 1.8k 1.3× 590 0.6× 811 1.3× 293 1.1× 388 1.6× 102 3.0k
Jérôme Tamburini France 31 2.2k 1.5× 446 0.4× 540 0.9× 373 1.4× 284 1.2× 88 3.3k
Joseph Kwong Hong Kong 32 1.6k 1.2× 757 0.8× 803 1.3× 213 0.8× 241 1.0× 56 2.8k
Jianyin Long United States 21 2.4k 1.7× 889 0.9× 513 0.8× 181 0.7× 132 0.5× 28 3.1k
Arja Jukkola‐Vuorinen Finland 25 898 0.6× 800 0.8× 1.0k 1.7× 211 0.8× 341 1.4× 51 2.2k
Jiong Bi China 27 1.7k 1.2× 1.0k 1.0× 594 1.0× 169 0.6× 265 1.1× 51 2.5k
Stephano S. Mello Brazil 20 2.0k 1.4× 856 0.9× 1.2k 1.9× 111 0.4× 293 1.2× 38 2.9k
Christos K. Kontos Greece 31 1.7k 1.2× 1.2k 1.2× 607 1.0× 241 0.9× 202 0.8× 122 2.7k
Huamei Tang China 34 2.1k 1.5× 1.2k 1.2× 656 1.1× 378 1.4× 361 1.5× 83 2.9k

Countries citing papers authored by Enping Xu

Since Specialization
Citations

This map shows the geographic impact of Enping Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Enping Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Enping Xu more than expected).

Fields of papers citing papers by Enping Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Enping Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Enping Xu. The network helps show where Enping Xu may publish in the future.

Co-authorship network of co-authors of Enping Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Enping Xu. A scholar is included among the top collaborators of Enping Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Enping Xu. Enping Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Han, Fengyan, Xiaoxu Zhou, Lu Liu, et al.. (2024). GLTSCR1 deficiency promotes colorectal cancer development through regulating non-homologous end joining. Oncogene. 43(48). 3517–3531.
2.
Chen, Chaoyi, Fengyan Han, Jingwen Deng, et al.. (2023). AMER1 deficiency promotes the distant metastasis of colorectal cancer by inhibiting SLC7A11- and FTL-mediated ferroptosis. Cell Reports. 42(9). 113110–113110. 26 indexed citations
3.
Han, Fengyan, Beibei Yang, Yan Chen, et al.. (2023). Loss of GLTSCR1 causes congenital heart defects by regulating NPPA transcription. Angiogenesis. 26(2). 217–232. 6 indexed citations
5.
Wang, Yan, et al.. (2021). Methylation status of ADAM12 promoter are associated with its expression levels in colorectal cancer. Pathology - Research and Practice. 221. 153449–153449. 3 indexed citations
6.
Wang, Yan, et al.. (2021). Research progress on application of microhaplotype in forensic genetics. Journal of Zhejiang University (Medical Sciences). 50(6). 777–782. 1 indexed citations
7.
Lai, Chong, Wenjie Sun, Xiaosheng Wang, et al.. (2019). RNF43 frameshift mutations contribute to tumourigenesis in right-sided colon cancer. Pathology - Research and Practice. 215(8). 152453–152453. 12 indexed citations
8.
Wan, Ledong, Wenying Yu, Enhui Shen, et al.. (2017). SRSF6-regulated alternative splicing that promotes tumour progression offers a therapy target for colorectal cancer. Gut. 68(1). 118–129. 134 indexed citations
9.
Cao, Hui, Enping Xu, Hong Liu, Ledong Wan, & Maode Lai. (2015). Epithelial–mesenchymal transition in colorectal cancer metastasis: A system review. Pathology - Research and Practice. 211(8). 557–569. 295 indexed citations
10.
Zhang, Honghe, Peiwei Li, Martin Pešta, et al.. (2014). Diagnostic and Prognostic Value of microRNA-21 in Colorectal Cancer: An Original Study and Individual Participant Data Meta-analysis. Cancer Epidemiology Biomarkers & Prevention. 23(12). 2783–2792. 24 indexed citations
11.
Zhang, Honghe, Jinlong Tang, Chen Li, et al.. (2014). MiR-22 regulates 5-FU sensitivity by inhibiting autophagy and promoting apoptosis in colorectal cancer cells. Cancer Letters. 356(2). 781–790. 139 indexed citations
12.
Li, Fengying, Xiaobin Ren, Enping Xu, et al.. (2010). RegIV expression showing specificity to gastrointestinal tract and its potential role in diagnosing digestive tract neuroendocrine tumor. Journal of Zhejiang University SCIENCE B. 11(4). 258–266. 13 indexed citations
13.
Xu, Enping, Xiaoping Xia, Bingjian Lü, et al.. (2007). Association of matrix metalloproteinase‐2 and ‐9 promoter polymorphisms with colorectal cancer in Chinese. Molecular Carcinogenesis. 46(11). 924–929. 34 indexed citations
14.
Lü, Bingjian, Jing Xu, Jian Chen, et al.. (2007). TaqMan low density array is roughly right for gene expression quantification in colorectal cancer. Clinica Chimica Acta. 389(1-2). 146–151. 13 indexed citations
15.
Ruan, Wenjing, Enping Xu, Fangying Xu, et al.. (2007). IGFBP7 plays a potential tumor suppressor role in colorectal carcinogenesis. Cancer Biology & Therapy. 6(3). 354–359. 87 indexed citations
16.
Xing, Xiaoming, Maode Lai, Wolfgang Gärtner, et al.. (2006). Identification of differentially expressed proteins in colorectal cancer by proteomics: Down‐regulation of secretagogin. PROTEOMICS. 6(9). 2916–2923. 43 indexed citations
17.
Xu, Enping, Maode Lai, Bingjian Lü, Xiaoming Xing, & Qiong Huang. (2006). No Association Between the Polymorphisms in Matrix Metalloproteinase-1 and Matrix Metalloproteinase-3 Promoter Regions and Colorectal Cancer in Chinese. Diseases of the Colon & Rectum. 49(9). 1439–1444. 21 indexed citations
18.
Lai, Maode, Bingjian Lü, Xiaoming Xing, et al.. (2006). Secretagogin, a novel neuroendocrine marker, has a distinct expression pattern from chromogranin A. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 449(4). 402–409. 27 indexed citations
19.
Xu, Enping, Maode Lai, Bingjian Lv, et al.. (2005). DHPLC analysis of the matrix metalloproteinase-1 promoter 1G/2G polymorphism that can be easily used to screen large population. Journal of Biochemical and Biophysical Methods. 63(3). 222–227. 2 indexed citations
20.
Xu, Enping, Maode Lai, Bingjian Lv, et al.. (2004). A single nucleotide polymorphism in the matrix metalloproteinase-2 promoter is associated with colorectal cancer. Biochemical and Biophysical Research Communications. 324(3). 999–1003. 66 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026